Publication | Open Access
Antipyrine metabolism in acute hepatic porphyria in relapse and remission.
17
Citations
11
References
1987
Year
Porphyric AttackAntipyrine KineticsPharmacotherapyAntipyrine MetabolismPharmacological StudyPorphyrin PrecursorsToxicologyHepatotoxicityHealth SciencesLiver PhysiologyEndocrinologyPharmacologyDrug-induced Liver InjuryPorphyriasHepatologyPhysiologyAcute Liver FailureLiver DiseaseMetabolismMedicinePharmacokinetics
Antipyrine kinetics following a single oral dose were obtained in porphyric patients in attack and in remission and in controls. The clearance of antipyrine was significantly lower during an acute porphyric attack (median: 0.34 ml min-1 kg-1; range: 0.1-0.71, P less than 0.05) than in patients in remission (median: 0.53 ml min-1 kg-1; range: 0.28-0.87) or controls (median: 0.52 ml min-1 kg-1; range: 0.32-0.93). There was a significant negative correlation between weight-adjusted antipyrine clearance and the urinary excretion of the porphyrin precursors, delta-aminolaevulinic acid (r = 0.86, P less than 0.001) and porphobilinogen (r = 0.82, P less than 0.002). These data suggest that the more severe the porphyric attack, the greater the impairment of hepatic monooxygenase activity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1